Balakrishna Koneru
5PUBLICATIONS
55CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Mar 18, 2026
Tabular foundation model predicts alternative lengthening of telomeres (ALT) and identifies SMARCAL1 as a target in ALT-driven cancers.D Bennett, M Wierdl, S Chakraborty
|Mar 04, 2025
Frequency and Clinical Significance of Clonal and Subclonal Driver Mutations in High-Risk Neuroblastoma at Diagnosis: A Children's Oncology Group Study.Esther R Berko, Arlene Naranjo, Alexander A Daniels
|Aug 10, 2022
Alternative Lengthening of Telomeres in Cancer Confers a Vulnerability to Reactivation of p53 Function.Shawn J Macha, Balakrishna Koneru, Trevor A Burrow
|Aug 19, 2021
ALT neuroblastoma chemoresistance due to telomere dysfunction-induced ATM activation is reversible with ATM inhibitor AZD0156.Balakrishna Koneru, Ahsan Farooqi, Thinh H Nguyen
|Apr 16, 2020
Telomere Maintenance Mechanisms Define Clinical Outcome in High-Risk Neuroblastoma.Balakrishna Koneru, Gonzalo Lopez, Ahsan Farooqi
Pageof 1
Frequent Collaborators
3 joint publications
C Patrick Reynolds
2 joint publications
Cody Eslinger
2 joint publications
John M Maris
1 joint publications
Yael P Mossé
1 joint publications
V Akingbehin
1 joint publications
D Estevez-Prado
1 joint publications
J J Morsby
1 joint publications
M A Mohammad Nezhady
1 joint publications
N Ocasio-Martinez
1 joint publications
N V Dharia
